Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (515)	3/16/1999 2:01:00 AM
From: Jorgen Jensen	Read Replies (3) of 4974

I know you like to follow biotech companies during their infancy or development stages, so here is a little known Australian company named Progen Industries Ltd. It's lead compound is an angiogenesis inhibitor PI-88, and the company just announced the successful completion of phase l trials in healthy individuals. The news will be getting to the US shortly. Here is their web site: progen.com.au The company started trading on the Nasdaq last year, symbol PGLAF. Yes I own a few shares, but am not touting it. I would like however, your opinion of their science, and I have a folder full of company announcements, if you are interested. Thanks in advance. Jørgen

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next